Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccinia Virus Infection”

167 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 167 results

Early research (Phase 1)Study completedNCT00252148
What this trial is testing

Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

Who this might be right for
HIV Infection
International AIDS Vaccine Initiative 48
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Testing effectiveness (Phase 2)Ended earlyNCT03610581
What this trial is testing

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Who this might be right for
Human Papillomavirus Infections
Janssen Vaccines & Prevention B.V. 9
Large-scale testing (Phase 3)Study completedNCT02509494
What this trial is testing

Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo

Who this might be right for
Ebola Virus Disease
Janssen Vaccines & Prevention B.V. 1,023
Not applicableLooking for participantsNCT06616753
What this trial is testing

Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital

Who this might be right for
Vaccinia
Groupe Hospitalier Sud Ile-de-France 140
Early research (Phase 1)Looking for participantsNCT07001592
What this trial is testing

Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors

Who this might be right for
Gastric NeoplasmsEsophageal CancerLiver Cancer+9 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 18
Early research (Phase 1)Looking for participantsNCT06660056
What this trial is testing

A Phase I Clinical Study of Intratumoral Injection GC001 in Patient With Recurrent or Progressive Gliomas

Who this might be right for
High-grade Gliomas
GONGCHU Biotechnology Co., Ltd 35
Early research (Phase 1)Study completedNCT00000957
What this trial is testing

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT01766739
What this trial is testing

Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 18
Not applicableStudy completedNCT00928577
What this trial is testing

Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)

Who this might be right for
Smallpox
Emergent BioSolutions 14,108
Post-approval studies (Phase 4)Study completedNCT03472014
What this trial is testing

Special Access Program IMVAMUNE®

Who this might be right for
Vaccination
Bavarian Nordic 22
Large-scale testing (Phase 3)Study completedNCT01143181
What this trial is testing

Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses

Who this might be right for
Double-stranded DNA Virus
Jazz Pharmaceuticals 210
Testing effectiveness (Phase 2)Ended earlyNCT01329809
What this trial is testing

Neoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoing Complete Resection of Liver Tumors

Who this might be right for
Colorectal Carcinoma
Jennerex Biotherapeutics 2
Testing effectiveness (Phase 2)Study completedNCT01394939
What this trial is testing

Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaCRC
Jennerex Biotherapeutics 52
Not applicableStudy completedNCT00407069
What this trial is testing

Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus

Who this might be right for
Atopic Dermatitis
National Institute of Allergy and Infectious Diseases (NIAID) 286
Large-scale testing (Phase 3)Study completedNCT01056770
What this trial is testing

Safety and Efficacy of CJ Smallpox Vaccine in Healthy Volunteers

Who this might be right for
Smallpox
Seoul National University Hospital 88
Testing effectiveness (Phase 2)Study completedNCT01668537
What this trial is testing

A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects

Who this might be right for
Smallpox
Bavarian Nordic 651
Large-scale testing (Phase 3)Active Not RecruitingNCT06844500
What this trial is testing

Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC

Who this might be right for
NeonateMaternal TransmissionMpox+5 more
Jean-Pierre Van geertruyden 359
Early research (Phase 1)Study completedNCT00000631
What this trial is testing

A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (VaxSyn)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 13
Early research (Phase 1)Study completedNCT00423839
What this trial is testing

A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers

Who this might be right for
Tuberculosis
University of Oxford 12
Load More Results